Mirum Pharmaceuticals, Inc. (MIRM) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19
	8-K	10-K	10-K	10-K
Assets
Cash and equivalents		31.3	142.1	12.0
Short-term investments		125.2	89.7	104.7
Accounts receivable, net		3.3
Inventories		1.5
Other current assets		5.3	4.5	2.7
Total current assets		166.6	236.4	119.4
Property, plant, and equipment, net		1.0	1.3	1.4
Intangibles		18.7
Long-term investments		10.0		46.6
Other fixed assets		1.8	1.3	0.3
Total assets		294.7	240.9	146.7

Accounts payable		9.2	3.2	3.4
Accrued expenses		30.7	13.4	9.3
Short-term debt		0.0	0.0	0.0
Other current liabilities		2.7	1.9	0.4
Total current liabilities		42.6	18.5	13.1
Other liabilities		131.8	50.3	3.3
Total liabilities		174.4	68.8	16.4

Shareholders' equity [+]		120.2	172.1	130.3
Paid-in capital		377.4	345.2	200.1
Retained earnings		-257.2	-173.2	-69.9
Tangible shareholders' equity		101.5	172.1	130.3